We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Defining "payers"
- Managed Care Organizations (MCOs)
- Regional health plans
- Integrated Delivery Network (IDN)
- Pharmacy Benefit Manager (PBM)
- Medicare
- Introduction to payer management
- Types of drug administration
- Formulary management
- Pharmacy and Therapeutics (P&T) Committees
- Formulary review process
- Utilization management
- Patient affordability
- Vertical integration
- Considerations for the US healthcare system
- Thank you!
Topics Covered
- Managed Care Organizations (MCOs)
- Integrated Delivery Network (IDN)
- Pharmacy Benefit Manager (PBM)
- Medicare
- Drug administration
- Formulary management and review process
- P&T committee
Talk Citation
Kelly, K. (2025, June 30). The US payer landscape [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved August 3, 2025, from https://doi.org/10.69645/HRIA4055.Export Citation (RIS)
Publication History
- Published on June 30, 2025
Financial Disclosures
- There are no commercial/financial matters to disclose.
Other Talks in the Series: Pharmaceutical Marketing
Transcript
Please wait while the transcript is being prepared...
0:00
Hello. I'm Keith Kelly and I'm
happy to talk to you about
the US payer landscape on
behalf of Henry Stewart Talks.
0:09
The term payer is the title
of the talk and is
itself confusing.
It can be used to
refer to a variety of
US healthcare
industry stakeholders
who determine patient
access to therapies.
It's used to apply to
these different stakeholders
the term payer.
This slide has the funders.
These are the sources of
payment for insurance coverage.
What's important to
note here is that
roughly 50% of your coverage
comes from commercial
insurance providers,
these are your MCOs and
your payer-like IDNs,
and about half of it comes
from government sources like
the Center for Medicare and
Medicaid Services as
well as the VA and DoD.
0:53
This slide covers Managed
Care Organizations.
These are the organizations
that administer
health plans and
the five largest
of these organizations represent
more than 40% of
the 314 million covered
lives in the United States.
What has happened in the
last 10 years is that
there's been tremendous
consolidation among
the Managed Care
Organizations arriving at
that greater than 40% represented
in the top five figure.
Here are the top five
US health insurers.
They are United Health Group,
Elevance Health, Aetna,
Cigna and Humana.
What has changed in terms of
accessing these payers if
you're bringing a product
or a technology to them is
that, historically because
the US Healthcare
System was fragmented,
you could afford to win some
payers and lose some payers.
Now with these payers having
so many covered lives
within their benefits,
you really have to try to
reach each and every one of
these payers and have them
approve or decide to
reimburse your technology.
Let's talk about the other
half of US enrollment in